In our case and using immunocompetent mice, MVA-ZIKV is able to induce potent and polyfunctional ZIKV-specific CD8+ T cell immune responses, as natural ZIKV infection does29, indicating that MVA-ZIKV could be a promising vaccine candidate against ZIKV. This evidence concerns the gene CD8A and Zika virus infectious disease.